Racura Oncology Ltd (RAC.AX)
Develops a cancer drug that stops tumor growth by blocking a key cancer-causing protein.
1.99-0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+71.6%
The outlook
RAC.AX is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage appears thin or unavailable. The overall sentiment leans bearish based on current price positioning and trend weakness.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range23% of the way from its 52-week low to high
Market cap
$390.2M
52-wk high
4.90
52-wk low
1.14
50-day avg
2.32
200-day avg
2.65
Trailing P/E
—